StonvexLoading…
StonvexStonvexStonvexCore line items from UMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $7.08B | $7.27B | $9.07B | $7.68B |
Operating Income | $1.57B | $1.89B | $3.39B | $1.86B |
Net Income | $1.48B | $1.96B | $2.94B | $1.82B |
EPS (Diluted) | $0.12 | $0.16 | $0.23 | $0.15 |
Total Assets | $17.08B | $17.85B | $17.07B | $16.26B |
Total Liabilities | $5.93B | $6.63B | $6.57B | $6.73B |
Cash & Equivalents | $3.20B | $4.04B | $5.68B | $4.32B |
Free Cash Flow OCF − CapEx | $162.50M | $-178.77M | $2.14B | $1.53B |
Shares Outstanding | 12.56B | 12.53B | 12.50B | 12.48B |